| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebrovascular Circulation | 34 | 2021 | 434 | 3.790 |
Why?
|
| Homeostasis | 29 | 2017 | 682 | 2.980 |
Why?
|
| Cardiopulmonary Bypass | 10 | 2017 | 343 | 1.870 |
Why?
|
| Spectroscopy, Near-Infrared | 12 | 2017 | 133 | 1.750 |
Why?
|
| Monitoring, Intraoperative | 11 | 2017 | 128 | 1.550 |
Why?
|
| Intracranial Pressure | 17 | 2021 | 182 | 1.410 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2017 | 104 | 1.080 |
Why?
|
| Heart Defects, Congenital | 9 | 2019 | 1806 | 1.000 |
Why?
|
| Blood Pressure | 22 | 2021 | 1325 | 0.940 |
Why?
|
| Intracranial Hypertension | 6 | 2016 | 120 | 0.810 |
Why?
|
| Blood Flow Velocity | 16 | 2021 | 450 | 0.790 |
Why?
|
| Ataxia Telangiectasia | 2 | 2012 | 15 | 0.790 |
Why?
|
| Ventilators, Mechanical | 2 | 2011 | 32 | 0.760 |
Why?
|
| Noninvasive Ventilation | 1 | 2021 | 31 | 0.750 |
Why?
|
| Acute Lung Injury | 5 | 2018 | 62 | 0.720 |
Why?
|
| Intensive Care Units, Pediatric | 8 | 2021 | 470 | 0.690 |
Why?
|
| High-Frequency Ventilation | 2 | 2011 | 16 | 0.690 |
Why?
|
| Dexmedetomidine | 3 | 2009 | 44 | 0.680 |
Why?
|
| Arterial Pressure | 9 | 2019 | 104 | 0.640 |
Why?
|
| Lung | 8 | 2009 | 1476 | 0.640 |
Why?
|
| Pulmonary Ventilation | 2 | 2009 | 28 | 0.640 |
Why?
|
| Monitoring, Physiologic | 8 | 2016 | 360 | 0.600 |
Why?
|
| Anesthetics, Intravenous | 2 | 2008 | 47 | 0.600 |
Why?
|
| Middle Cerebral Artery | 7 | 2019 | 110 | 0.600 |
Why?
|
| Venous Pressure | 2 | 2014 | 8 | 0.560 |
Why?
|
| Brain Injuries | 6 | 2017 | 762 | 0.550 |
Why?
|
| Swine | 16 | 2021 | 1155 | 0.520 |
Why?
|
| Anesthetics | 2 | 2019 | 81 | 0.510 |
Why?
|
| Cardiac Surgical Procedures | 8 | 2019 | 1099 | 0.510 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2012 | 2058 | 0.510 |
Why?
|
| Optic Nerve | 2 | 2014 | 117 | 0.500 |
Why?
|
| Oximetry | 9 | 2013 | 160 | 0.500 |
Why?
|
| Hemoglobins | 3 | 2013 | 301 | 0.490 |
Why?
|
| Postoperative Complications | 6 | 2019 | 3014 | 0.470 |
Why?
|
| Blood Pressure Determination | 3 | 2019 | 105 | 0.470 |
Why?
|
| Pulmonary Circulation | 3 | 2009 | 121 | 0.460 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 195 | 0.440 |
Why?
|
| Hypothermia, Induced | 4 | 2017 | 161 | 0.440 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2017 | 228 | 0.440 |
Why?
|
| Coronary Vessels | 1 | 2017 | 526 | 0.430 |
Why?
|
| Lung Injury | 2 | 2011 | 122 | 0.410 |
Why?
|
| Cerebral Hemorrhage | 4 | 2019 | 143 | 0.410 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2013 | 169 | 0.400 |
Why?
|
| Infant, Newborn | 20 | 2019 | 8108 | 0.390 |
Why?
|
| Mass Casualty Incidents | 1 | 2011 | 17 | 0.390 |
Why?
|
| Perioperative Period | 1 | 2011 | 50 | 0.380 |
Why?
|
| Hypoxia | 2 | 2019 | 247 | 0.380 |
Why?
|
| Hypnotics and Sedatives | 2 | 2009 | 135 | 0.370 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2008 | 51 | 0.360 |
Why?
|
| Critical Illness | 3 | 2015 | 591 | 0.360 |
Why?
|
| Thrombosis | 2 | 2016 | 520 | 0.350 |
Why?
|
| Thromboembolism | 1 | 2011 | 84 | 0.350 |
Why?
|
| Extravascular Lung Water | 1 | 2009 | 2 | 0.340 |
Why?
|
| Thermodilution | 1 | 2009 | 10 | 0.340 |
Why?
|
| Deep Sedation | 1 | 2009 | 6 | 0.340 |
Why?
|
| Venous Thrombosis | 1 | 2011 | 180 | 0.330 |
Why?
|
| Intracranial Hemorrhages | 3 | 2013 | 73 | 0.330 |
Why?
|
| Chest Wall Oscillation | 1 | 2009 | 2 | 0.330 |
Why?
|
| Respiration, Artificial | 6 | 2021 | 451 | 0.320 |
Why?
|
| Anesthesia | 1 | 2011 | 211 | 0.310 |
Why?
|
| Humans | 53 | 2021 | 123224 | 0.310 |
Why?
|
| Midazolam | 1 | 2008 | 49 | 0.310 |
Why?
|
| Child | 18 | 2021 | 24241 | 0.310 |
Why?
|
| Heart Bypass, Right | 1 | 2008 | 17 | 0.300 |
Why?
|
| Hypotension | 4 | 2012 | 177 | 0.300 |
Why?
|
| Anesthetics, Combined | 1 | 2007 | 7 | 0.300 |
Why?
|
| Brain | 7 | 2019 | 2964 | 0.300 |
Why?
|
| Positive-Pressure Respiration | 4 | 2012 | 83 | 0.300 |
Why?
|
| Linear Models | 5 | 2019 | 669 | 0.290 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2008 | 141 | 0.290 |
Why?
|
| Dogs | 7 | 2009 | 765 | 0.280 |
Why?
|
| Infant, Premature | 8 | 2019 | 799 | 0.280 |
Why?
|
| Pneumonia | 2 | 2012 | 325 | 0.270 |
Why?
|
| Male | 36 | 2019 | 60118 | 0.270 |
Why?
|
| Infant | 16 | 2017 | 12350 | 0.270 |
Why?
|
| Female | 35 | 2019 | 65550 | 0.270 |
Why?
|
| Tidal Volume | 3 | 2011 | 36 | 0.270 |
Why?
|
| Infant, Premature, Diseases | 3 | 2019 | 239 | 0.270 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2017 | 621 | 0.270 |
Why?
|
| Animals | 29 | 2021 | 33759 | 0.270 |
Why?
|
| Laser-Doppler Flowmetry | 8 | 2017 | 56 | 0.260 |
Why?
|
| Sepsis | 3 | 2009 | 477 | 0.260 |
Why?
|
| Clostridium perfringens | 1 | 2005 | 7 | 0.260 |
Why?
|
| Compartment Syndromes | 1 | 2006 | 31 | 0.260 |
Why?
|
| Sickle Cell Trait | 1 | 2005 | 11 | 0.260 |
Why?
|
| Diastole | 5 | 2019 | 169 | 0.260 |
Why?
|
| Abdomen | 1 | 2006 | 130 | 0.250 |
Why?
|
| Pilot Projects | 6 | 2017 | 1388 | 0.250 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 7 | 2021 | 109 | 0.230 |
Why?
|
| Prospective Studies | 11 | 2017 | 6040 | 0.230 |
Why?
|
| Analgesics, Opioid | 1 | 2008 | 402 | 0.230 |
Why?
|
| Anesthesia, Epidural | 1 | 2003 | 14 | 0.220 |
Why?
|
| Coronary Vasospasm | 1 | 2003 | 10 | 0.220 |
Why?
|
| Jugular Veins | 2 | 2014 | 75 | 0.220 |
Why?
|
| Models, Animal | 6 | 2017 | 464 | 0.210 |
Why?
|
| ROC Curve | 4 | 2013 | 557 | 0.210 |
Why?
|
| Multivariate Analysis | 5 | 2017 | 1414 | 0.200 |
Why?
|
| Logistic Models | 4 | 2017 | 1793 | 0.200 |
Why?
|
| Animals, Newborn | 10 | 2017 | 991 | 0.200 |
Why?
|
| Clostridium Infections | 1 | 2005 | 238 | 0.200 |
Why?
|
| Cannula | 1 | 2021 | 28 | 0.190 |
Why?
|
| Heart Arrest | 2 | 2017 | 340 | 0.190 |
Why?
|
| Spectrum Analysis | 1 | 2021 | 61 | 0.180 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 3 | 2018 | 15 | 0.180 |
Why?
|
| Airway Extubation | 1 | 2021 | 67 | 0.180 |
Why?
|
| Child, Preschool | 11 | 2017 | 13888 | 0.180 |
Why?
|
| Cytokines | 3 | 2018 | 1285 | 0.180 |
Why?
|
| Disease Models, Animal | 12 | 2016 | 4273 | 0.180 |
Why?
|
| Adolescent | 11 | 2017 | 19110 | 0.180 |
Why?
|
| Pulmonary Surfactants | 2 | 2018 | 43 | 0.170 |
Why?
|
| Coronary Artery Bypass | 2 | 2013 | 486 | 0.170 |
Why?
|
| Biomarkers | 5 | 2017 | 2946 | 0.160 |
Why?
|
| Hospital Mortality | 3 | 2013 | 1009 | 0.160 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2019 | 78 | 0.150 |
Why?
|
| Algorithms | 5 | 2019 | 1593 | 0.150 |
Why?
|
| Lung Volume Measurements | 2 | 2008 | 74 | 0.150 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2018 | 27 | 0.150 |
Why?
|
| Catheterization | 2 | 2010 | 235 | 0.140 |
Why?
|
| Perioperative Care | 3 | 2017 | 195 | 0.140 |
Why?
|
| Intubation, Intratracheal | 1 | 2000 | 291 | 0.140 |
Why?
|
| Perfusion | 2 | 2019 | 197 | 0.130 |
Why?
|
| Electrocardiography | 2 | 2017 | 958 | 0.130 |
Why?
|
| Carbon Dioxide | 3 | 2011 | 274 | 0.130 |
Why?
|
| Sheep | 4 | 2012 | 208 | 0.130 |
Why?
|
| Cerebral Ventricles | 1 | 2016 | 81 | 0.130 |
Why?
|
| Heart Ventricles | 2 | 2017 | 759 | 0.120 |
Why?
|
| Electroencephalography | 2 | 2019 | 863 | 0.120 |
Why?
|
| Regression Analysis | 2 | 2019 | 771 | 0.120 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2016 | 237 | 0.120 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 485 | 0.110 |
Why?
|
| Growth Disorders | 1 | 2016 | 207 | 0.110 |
Why?
|
| Young Adult | 3 | 2013 | 8865 | 0.110 |
Why?
|
| Ketamine | 2 | 2008 | 214 | 0.110 |
Why?
|
| Ultrasonography | 3 | 2014 | 940 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 280 | 0.110 |
Why?
|
| Rewarming | 1 | 2013 | 12 | 0.110 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2017 | 252 | 0.110 |
Why?
|
| In Vitro Techniques | 2 | 2014 | 966 | 0.110 |
Why?
|
| Sleep Wake Disorders | 1 | 2015 | 173 | 0.110 |
Why?
|
| Heart Valves | 1 | 2013 | 51 | 0.110 |
Why?
|
| Aerospace Medicine | 1 | 2013 | 37 | 0.110 |
Why?
|
| Oxygen Consumption | 2 | 2011 | 307 | 0.110 |
Why?
|
| Vena Cava, Superior | 1 | 2013 | 55 | 0.110 |
Why?
|
| Respiratory Insufficiency | 2 | 2015 | 232 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 2026 | 0.110 |
Why?
|
| Echoencephalography | 1 | 2013 | 25 | 0.110 |
Why?
|
| Pain, Postoperative | 1 | 2016 | 256 | 0.110 |
Why?
|
| Erythrocyte Transfusion | 1 | 2014 | 122 | 0.100 |
Why?
|
| Medical Order Entry Systems | 1 | 2014 | 98 | 0.100 |
Why?
|
| Renal Circulation | 1 | 2012 | 45 | 0.100 |
Why?
|
| Xenon | 2 | 2009 | 11 | 0.100 |
Why?
|
| Preanesthetic Medication | 1 | 2011 | 3 | 0.100 |
Why?
|
| Respiratory Rate | 1 | 2011 | 4 | 0.100 |
Why?
|
| Renal Artery | 1 | 2012 | 74 | 0.100 |
Why?
|
| Erythropoietin | 1 | 2012 | 104 | 0.100 |
Why?
|
| Vascular Resistance | 3 | 2019 | 189 | 0.100 |
Why?
|
| Resuscitation | 1 | 2014 | 244 | 0.100 |
Why?
|
| Space Flight | 1 | 2013 | 113 | 0.100 |
Why?
|
| Functional Laterality | 1 | 2012 | 181 | 0.100 |
Why?
|
| Endotoxemia | 1 | 2012 | 56 | 0.100 |
Why?
|
| Nervous System | 1 | 2012 | 128 | 0.100 |
Why?
|
| Umbilical Arteries | 3 | 2016 | 89 | 0.090 |
Why?
|
| Body Temperature | 2 | 2009 | 110 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2014 | 375 | 0.090 |
Why?
|
| Lipopolysaccharides | 2 | 2009 | 290 | 0.090 |
Why?
|
| Shock | 1 | 2012 | 90 | 0.090 |
Why?
|
| Airway Management | 1 | 2011 | 66 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2016 | 581 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 150 | 0.090 |
Why?
|
| Gestational Age | 4 | 2016 | 1138 | 0.090 |
Why?
|
| Transposition of Great Vessels | 1 | 2012 | 132 | 0.090 |
Why?
|
| Anesthesia, General | 1 | 2011 | 111 | 0.090 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2016 | 370 | 0.090 |
Why?
|
| Infant, Extremely Premature | 3 | 2016 | 81 | 0.090 |
Why?
|
| Treatment Outcome | 5 | 2013 | 12141 | 0.090 |
Why?
|
| Retrospective Studies | 6 | 2017 | 16033 | 0.090 |
Why?
|
| Likelihood Functions | 1 | 2010 | 112 | 0.090 |
Why?
|
| Anemia, Sickle Cell | 1 | 2014 | 334 | 0.090 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2009 | 16 | 0.090 |
Why?
|
| Oxygen | 2 | 2011 | 547 | 0.090 |
Why?
|
| Child Development | 1 | 2012 | 261 | 0.080 |
Why?
|
| Renal Insufficiency | 1 | 2012 | 233 | 0.080 |
Why?
|
| Risk | 1 | 2011 | 747 | 0.080 |
Why?
|
| United States | 2 | 2017 | 10637 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 229 | 0.080 |
Why?
|
| Conscious Sedation | 1 | 2009 | 63 | 0.080 |
Why?
|
| Intracranial Hypotension | 1 | 2008 | 10 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 372 | 0.080 |
Why?
|
| Biophysics | 1 | 2008 | 49 | 0.080 |
Why?
|
| Risk Factors | 5 | 2019 | 10015 | 0.080 |
Why?
|
| Nursing Assessment | 1 | 2008 | 26 | 0.080 |
Why?
|
| Pressure | 1 | 2008 | 130 | 0.080 |
Why?
|
| Hydrochloric Acid | 1 | 2008 | 14 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2012 | 1472 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2012 | 483 | 0.080 |
Why?
|
| Supine Position | 1 | 2008 | 24 | 0.080 |
Why?
|
| Anesthetics, Dissociative | 1 | 2008 | 20 | 0.070 |
Why?
|
| Propofol | 1 | 2007 | 44 | 0.070 |
Why?
|
| Respiratory Mechanics | 1 | 2008 | 75 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2011 | 485 | 0.070 |
Why?
|
| Aorta, Thoracic | 1 | 2012 | 519 | 0.070 |
Why?
|
| Kidney Function Tests | 1 | 2008 | 126 | 0.070 |
Why?
|
| Developmental Disabilities | 1 | 2012 | 699 | 0.070 |
Why?
|
| Lung Diseases | 2 | 2008 | 385 | 0.070 |
Why?
|
| Factor VIIa | 1 | 2006 | 24 | 0.070 |
Why?
|
| Postoperative Period | 1 | 2007 | 330 | 0.070 |
Why?
|
| Analgesics | 1 | 2007 | 135 | 0.070 |
Why?
|
| Models, Biological | 1 | 2011 | 1441 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 730 | 0.070 |
Why?
|
| Critical Care | 1 | 2011 | 648 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 1012 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 613 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2006 | 356 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 2008 | 439 | 0.060 |
Why?
|
| Severity of Illness Index | 4 | 2016 | 2839 | 0.060 |
Why?
|
| Stroke | 1 | 2012 | 958 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2005 | 462 | 0.060 |
Why?
|
| Prevalence | 1 | 2011 | 2406 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 1000 | 0.060 |
Why?
|
| Middle Aged | 8 | 2013 | 26016 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 2012 | 1026 | 0.060 |
Why?
|
| Adult | 4 | 2012 | 29072 | 0.060 |
Why?
|
| Angina, Unstable | 1 | 2003 | 52 | 0.050 |
Why?
|
| Cardiac Catheterization | 1 | 2008 | 631 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2006 | 459 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2006 | 1682 | 0.050 |
Why?
|
| Pediatrics | 1 | 2011 | 1141 | 0.050 |
Why?
|
| Hemodynamics | 2 | 2019 | 845 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2016 | 1243 | 0.050 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 2112 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2013 | 1008 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2006 | 976 | 0.040 |
Why?
|
| Aged | 6 | 2013 | 19098 | 0.040 |
Why?
|
| Pregnancy | 1 | 2013 | 7161 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 3546 | 0.040 |
Why?
|
| Hemodilution | 1 | 2019 | 15 | 0.040 |
Why?
|
| Oxyhemoglobins | 1 | 2019 | 22 | 0.040 |
Why?
|
| Time Factors | 3 | 2015 | 6221 | 0.040 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2019 | 41 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2016 | 4710 | 0.040 |
Why?
|
| Patient Admission | 1 | 2000 | 184 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2012 | 159 | 0.040 |
Why?
|
| Blood Gas Analysis | 2 | 2009 | 82 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2018 | 36 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2019 | 312 | 0.030 |
Why?
|
| Texas | 2 | 2017 | 3560 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2012 | 6372 | 0.030 |
Why?
|
| Coronary Care Units | 1 | 2016 | 36 | 0.030 |
Why?
|
| Feeding Methods | 1 | 2016 | 37 | 0.030 |
Why?
|
| Apgar Score | 1 | 2016 | 48 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2016 | 57 | 0.030 |
Why?
|
| Analgesia | 1 | 2016 | 44 | 0.030 |
Why?
|
| Failure to Thrive | 1 | 2016 | 90 | 0.030 |
Why?
|
| Systole | 1 | 2016 | 196 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 863 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 667 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 2016 | 180 | 0.030 |
Why?
|
| Histones | 1 | 2018 | 526 | 0.030 |
Why?
|
| Pain Management | 1 | 2016 | 175 | 0.030 |
Why?
|
| Seizures | 1 | 2019 | 873 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 2394 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 2014 | 57 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 1284 | 0.030 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2013 | 17 | 0.030 |
Why?
|
| Central Venous Pressure | 1 | 2013 | 25 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2013 | 313 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 2830 | 0.030 |
Why?
|
| Sleep | 1 | 2015 | 345 | 0.030 |
Why?
|
| Lung Compliance | 1 | 2012 | 19 | 0.030 |
Why?
|
| Operative Time | 1 | 2013 | 160 | 0.030 |
Why?
|
| Blood Volume Determination | 1 | 2012 | 9 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 1386 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2012 | 235 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 159 | 0.020 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2011 | 13 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 3274 | 0.020 |
Why?
|
| Reperfusion Injury | 1 | 2011 | 102 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 393 | 0.020 |
Why?
|
| Respiratory-Gated Imaging Techniques | 1 | 2009 | 1 | 0.020 |
Why?
|
| Coma | 1 | 2009 | 54 | 0.020 |
Why?
|
| Mice | 3 | 2018 | 17503 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2009 | 204 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2009 | 104 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 4353 | 0.020 |
Why?
|
| Posture | 1 | 2009 | 152 | 0.020 |
Why?
|
| Physiology | 1 | 2008 | 14 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 924 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2008 | 122 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 2008 | 79 | 0.020 |
Why?
|
| Diuresis | 1 | 2008 | 58 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 1726 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2008 | 169 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2008 | 178 | 0.020 |
Why?
|
| Respiration | 1 | 2008 | 123 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2008 | 134 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 425 | 0.020 |
Why?
|
| Vitamin K Deficiency | 1 | 2006 | 3 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2009 | 258 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2009 | 240 | 0.020 |
Why?
|
| Quality of Life | 1 | 2016 | 1929 | 0.020 |
Why?
|
| Creatinine | 1 | 2008 | 380 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2006 | 170 | 0.020 |
Why?
|
| Species Specificity | 1 | 2006 | 548 | 0.020 |
Why?
|
| Blood Coagulation Disorders | 1 | 2006 | 100 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 577 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2008 | 475 | 0.020 |
Why?
|
| Heart Rate | 1 | 2008 | 586 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2008 | 481 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 3048 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 849 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2005 | 382 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2006 | 223 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 1093 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 1151 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 892 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2005 | 623 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 697 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 5049 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 514 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 1584 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 2802 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 2696 | 0.010 |
Why?
|
| Prognosis | 1 | 2009 | 4514 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 1566 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 3868 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 2771 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 3653 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2006 | 1014 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2004 | 2586 | 0.010 |
Why?
|